Lexaria Highlights an $89 Billion Oral GLP-1 Opportunity as Novo Signals a Shift From Injections
Market Chameleon (Wed, 7-Oct 10:53 AM)
Lexaria Highlights $4.60 Per Share Cash on Hand After $7.9 Million Capital Boost
Market Chameleon (Fri, 18-Sep 9:57 AM)
